| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $33,817,369 ) (Continued on the next page) |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01CA233862 | A Treg cell-intrinsic CTLA4-PKC-eta signaling pathway mediating contact-dependent suppression of tumor immunity: A novel target for cancer immunotherapy | 000 | 4 | NIH | 11/22/2021 | $470,756 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI135193 | CD4 T cell, germinal center, and antibody response defects in recurrent tonsillitis | 001 | 5 | NIH | 6/9/2022 | $112,500 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI135193 | CD4 T cell, germinal center, and antibody response defects in recurrent tonsillitis | 000 | 5 | NIH | 6/2/2022 | $337,500 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | P01HL136275 | Immune Cell Interactions in Atherosclerosis | 002 | 6 | NIH | 7/13/2022 | -$2,358,435 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | P01HL136275 | Immune Cell Interactions in Atherosclerosis | 001 | 6 | NIH | 12/22/2021 | $2,648,176 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI128589 | Investigating the role of TET deficiency in promoting T cell expansion and inflammation | 000 | 6 | NIH | 6/7/2022 | $549,000 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | T32AI125179 | Training in Immunological Mechanisms | 006 | 6 | NIH | 8/2/2022 | $324,147 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI118626 | Respiratory pathogen-specific T cell signatures following vaccination, natural infection, and treatment | 001 | 8 | NIH | 5/9/2022 | $2,391,540 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R24AI108564 | Research Resources: Epigenomic and Transcriptomic Profile of Human Immune Cells | 000 | 8 | NIH | 7/12/2022 | $1,090,250 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI109842 | NFAT, bZIP proteins, and transcriptional programs in lymphocytes | 000 | 34 | NIH | 2/28/2022 | $842,353 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI134971 | Integrated Functional Histopathology of the Diabetic Human Pancreas | 000 | 5 | NIH | 11/17/2021 | $699,000 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI101423 | The role of TRAIL in immune control of cytomegalovirus | 000 | 9 | NIH | 5/18/2022 | $549,000 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R35GM147554 | Elucidating the signaling and protein interaction networks of the O-GlcNAc transferase during embryonic stem cell state transitions | 000 | 1 | NIH | 7/4/2022 | $457,500 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI167892 | HIPC Data Coordinating Center | 001 | 1 | NIH | 6/29/2022 | $0 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI167892 | HIPC Data Coordinating Center | 000 | 1 | NIH | 4/13/2022 | $3,001,925 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R37AI125068 | Maximizing germinal centers and somatic hypermutation to HIV Env immunogens | 000 | 7 | NIH | 2/2/2022 | $883,119 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U24CA248138 | THE CANCER EPITOPE DATABASE AND ANALYSIS RESOURCE | 000 | 2 | NIH | 6/16/2022 | $839,859 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI153500 | Maternal Antibody-Mediated Enhancement of Dengue Pathogenesis | 000 | 2 | NIH | 3/1/2022 | $725,399 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI163188 | Development of a Replicon RNA-based Vaccine against Dengue and Zika | 000 | 2 | NIH | 5/24/2022 | $712,699 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01CA256133 | Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy | 000 | 2 | NIH | 6/28/2022 | $706,425 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI143934 | The Role of Cytoplasmic and Nuclear THEMIS in Immature and Mature T cells | 000 | 3 | NIH | 1/18/2022 | $688,446 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01CA247500 | Exploring the potential of TET inhibition in cancer immunotherapy | 000 | 3 | NIH | 7/14/2022 | $492,576 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | F31DK124078 | The Role of Intestinal Epithelial Cells in the Generation of Protective CD4 Cytotoxic T Lymphocytes | 002 | 3 | NIH | 7/21/2022 | -$4,521 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | F31DK124078 | The Role of Intestinal Epithelial Cells in the Generation of Protective CD4 Cytotoxic T Lymphocytes | 001 | 3 | NIH | 5/2/2022 | $315 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | F31DK124078 | The Role of Intestinal Epithelial Cells in the Generation of Protective CD4 Cytotoxic T Lymphocytes | 000 | 3 | NIH | 1/20/2022 | $18,072 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI150753 | Developing computational models to predict the immune response to B. pertussis booster vaccination | 000 | 3 | NIH | 2/11/2022 | $1,351,458 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI139749 | CD4 T cell control of cytomegalovirus | 000 | 4 | NIH | 1/13/2022 | $615,063 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R35HL145241 | Vascular macrophages and T cells in atherosclerosis | 002 | 4 | NIH | 6/11/2022 | -$318,324 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R35HL145241 | Vascular macrophages and T cells in atherosclerosis | 001 | 4 | NIH | 4/27/2022 | $90,731 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R35HL145241 | Vascular macrophages and T cells in atherosclerosis | 000 | 4 | NIH | 2/7/2022 | $816,586 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI146042 | Histamine-Releasing Factor Oligomers in Food Allergy | 000 | 4 | NIH | 7/14/2022 | $634,331 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI142790 | Consortium for Immunotherapeutics against Emerging Viral Threats | 001 | 4 | NIH | 8/9/2022 | $0 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI142790 | Consortium for Immunotherapeutics against Emerging Viral Threats | 000 | 4 | NIH | 5/4/2022 | $7,020,842 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI142742 | Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses | 001 | 4 | NIH | 4/22/2022 | $1,616,471 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI142742 | Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses | 000 | 4 | NIH | 2/28/2022 | $2,714,133 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AR072640 | TWEAK and Skin Inflammation | 000 | 5 | NIH | 4/21/2022 | $392,040 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R35GM128938 | Defining interaction quantitative trait loci (iQTLs) in the human genome | 000 | 5 | NIH | 7/29/2022 | $449,784 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI141995 | Identifying mechanisms and correlates of long-lasting vaccine-induced immunity to whooping cough | 000 | 4 | NIH | 10/29/2021 | $823,202 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01CA233862 | A Treg cell-intrinsic CTLA4-PKC-eta signaling pathway mediating contact-dependent suppression of tumor immunity: A novel target for cancer immunotherapy | 001 | 4 | NIH | 6/22/2022 | $41,845 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI135731 | LJI Epitope Validation Center: Characterization of epitope-specific T cells responding to food, fungal and inner city allergens | 000 | 5 | NIH | 12/3/2021 | $1,153,559 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI137230 | Host nutrients permit immune evasion of NKT cell anti-bacterial responses | 000 | 5 | NIH | 12/14/2021 | $615,389 |
| | 2022 | 2021 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | K99CA248835 | Tumor suppressive functions of TET proteins in B cell malignancies: role of G-quadruplex structures | 001 | 2 | NIH | 7/8/2022 | -$21,042 |
| | 2022 | 2021 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | T32AI125179 | Training in Immunological Mechanisms | 008 | 5 | NIH | 8/9/2022 | $91,074 |
| | 2022 | 2021 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | T32AI125179 | Training in Immunological Mechanisms | 005 | 5 | NIH | 8/1/2022 | -$101,735 |
| | 2022 | 2021 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | T32AI125179 | Training in Immunological Mechanisms | 002 | 5 | NIH | 3/29/2022 | $101,735 |
| | 2022 | 2021 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | T32AI125179 | Training in Immunological Mechanisms | 003 | 5 | NIH | 4/5/2022 | $0 |
| | 2022 | 2021 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI118626 | Respiratory pathogen-specific T cell signatures following vaccination, natural infection, and treatment | 000 | 7 | NIH | 3/18/2022 | $0 |
| | 2022 | 2021 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | K99CA248835 | Tumor suppressive functions of TET proteins in B cell malignancies: role of G-quadruplex structures | 000 | 2 | NIH | 5/27/2022 | $0 |
| | 2022 | 2021 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01CA224766 | Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers | 000 | 4 | NIH | 8/10/2022 | $0 |
|
